Synairgen Plc Ord 1P is listed on the London Stock Exchange trading with ticker code SNG.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £1,477m, with approximately 109m shares in issue. Over the last year, Synairgen Plc share price has been traded in a range of 14.3, hitting a high of 26.50, and a low of 12.20.
Synairgen Plc, officially known as Synairgen Plc Ord 1P was formed in September of 2004, making the company fifteen years old. The company filed its latest accounts on 31st December 2014, showing a turnover of approximately 4.29 million GBX, and a pre-tax profit margin of 26.22%. Synairgen Plc currently has 8 directors, and has had 2 previous directors over the last 15 years. In the last set of accounts produced by Bdo Llp, the company showed 1.73 million paid in salaries to the 13 staff (average wage of 133 thousand), with the directors receiving an average 150 thousand each. In the accounts filed in 2014, the company paid 0 in dividends. These accounts also showed Synairgen Plc to have a net worth of 9.33 million, with 9.60 million held in cash.
Synairgen Plc is in the Medicine and Biotech Research sector.
Synairgen Plc is in the AIM 350 index.
|Evgen Pharma Plc (EVG.L)|
|Tiziana Life Sciences Plc (TILS.L)|
|Verona Pharma Plc Ord 0.1P (VRP.L)|
|Gulfsands Petroleum Plc (GPX.L)|
|Ixico Plc (IXI.L)|
|Shares in Issue||109m|
|52 Week High||26.50|
|52 Week Low||12.20|